Your browser doesn't support javascript.
loading
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Powles, T; Albiges, L; Bex, A; Comperat, E; Grünwald, V; Kanesvaran, R; Kitamura, H; McKay, R; Porta, C; Procopio, G; Schmidinger, M; Suarez, C; Teoh, J; de Velasco, G; Young, M; Gillessen, S.
Afiliação
  • Powles T; Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK.
  • Albiges L; Université Paris Saclay, Institut Gustave Roussy, Villejuif, France.
  • Bex A; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London; Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Comperat E; Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.
  • Grünwald V; Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Kitamura H; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • McKay R; Department of Medicine and Urology, University of California San Diego, La Jolla, USA.
  • Porta C; Interdisciplinary Department of Medicine, University of Bari 'A. Moro', Bari; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari.
  • Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Schmidinger M; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Teoh J; S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • de Velasco G; Instituto de Investigación i+12 and Departamento de Oncología Médica, Hospital University 12 de Octubre, Madrid, Spain.
  • Young M; Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK; Barts Cancer Institute, Department of Experimental Cancer Medicine, Queen Mary University of London, London, UK.
  • Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona; Università della Svizzera Italiana, Lugano, Switzerland.
Ann Oncol ; 35(8): 692-706, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38788900
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Estadiamento de Neoplasias Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Estadiamento de Neoplasias Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article